1. Back to Outputs Catalog

Investigating the Protective Role of the Mitochondrial 2158 T > C Variant in Parkinson’s Disease

January 10, 2025

Training and Networking Working Group Monogenic - Data Analysis Working Group

10.1002/mds.29892

View Article

Training and Networking Working Group

The Training and Networking working group promotes training and networking throughout the GP2 project.
Learn more about Training and Networking Working Group

Monogenic - Data Analysis Working Group

The Data Analysis working group carries out core analyses to identify the genetic basis of monogenic forms of Parkinson’s disease.
Learn more about Monogenic - Data Analysis Working Group

Meet the authors

Postdoctoral fellow

Fulya Akçimen, PhD,MSc

National Institutes of Health | Bethesda, MD, USA

Neurology resident and PhD Student

Vesna van Midden, MD

Ljubljana University Medical Centre | Ljubljana, Slovenia

Biomedical Data Scientist, Contractor

Mary B Makarious, PhD

National Institutes of Health | Washington D.C., USA

Scientist

Zih-Hua Fang, PhD

The German Center for Neurodegenerative Diseases | Tübingen, Germany

Staff Scientist

Sara Bandres-Ciga, PharmD,PhD

National Institutes of Health | USA

More outputs and publications

Towards a Global View of Parkinson's Disease Genetics
Description Parkinson\’s disease (PD) is a global health challenge, yet historically studies of PD have taken place predominantly in European populations. Recent genetics research conducted in non-European populations has revealed novel population-specific genetic loci linked to PD risk, highlighting the importance of studying PD globally. These insights have broadened our understanding of PD etiology, which […]
Read More
Mendelian Randomization and Parkinson's Disease
Description Integrative Omics in Parkinson’s Disease provides a comprehensive understanding of the current literature on high-throughput technologies relating to discoveries for Parkinson\’s disease etiology. This emerging field uses large omics datasets to investigate the etiology of Parkinson’s disease and other forms of parkinsonism. The book traces the evolution of omics technologies from the discovery of […]
Read More
Is SH3GL2 p.G276V the Causal Functional Variant Underlying Parkinson's Disease Risk at this Locus?
We read with great interest the article by Bademosi and colleagues, where they investigated the role of SH3GL2 p.G276V on neuron dysfunction in Parkinson's disease (PD).
Read More